UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 21, 2026
Sale
Calculated transaction value
$290.54K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 20, 2026
Public filing date
Oct 21, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$553.88
Oct 20, 2026
First close after public filing
$584.79
Oct 22, 2026
Return after filing · so far
+0.04%
Through Nov 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 520 shares @ $558.72
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000168
Filing cohort
Transactions in this filing
Showing 15 of 19
Trades
19
Issuers
1
Estimated value
$6.38M
Buys / sales
0 / 17
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $63.98K |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $520.4K |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $624.87K |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $860.88K |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $244.67K |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $178.28K |
| United Therapeutics Corp UTHR | Exercise | Oct 20, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $156.72K |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $698K |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $88.81K |
| United Therapeutics Corp UTHR Current | Sale | Oct 20, 2026 | $290.54K |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $176.61K |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $202.26K |
| United Therapeutics Corp UTHR | Sale | Oct 20, 2026 | $261.13K |
| United Therapeutics Corp UTHR | Exercise | Oct 20, 2026 | $0 |